Benzimidazole ribonucleosides: A new class of antivirals with potent and selective activity against human cytomegalovirus : J.C. Drach, L.B. Townsend, M.R. Nassiri, S.R. Turk, L.A. Coleman, R.V. Devivar, G. Genzlinger, E.D. Kreske, T.E. Renau, A.C. Westerman, and C. Shipman, Jr. University of Michigan, Ann Arbor, MI, 48109; K.K. Biron and R. Dornsife, Burroughs Wellcome Co., Research Triangle Park, NC 27709; E.R. Kern, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
- 31 March 1992
- journal article
- abstracts
- Published by Elsevier in Antiviral Research
- Vol. 17, 49
- https://doi.org/10.1016/0166-3542(92)90110-q
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: